AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycigon M 40mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Glycigon M 40mg/500mg Tablet

Diabetace Duo 40mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer Diabetace Duo 40mg/500mg with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption should be minimized due to its hypoglycemic risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glycigon M 40mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glycigon M 40mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 40mg/500mg Glycigon M Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glycigon M 40mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glycigon M 40mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glycigon M 40mg/500mg Tablets. These tablets should be swallowed whole; do not break, crush, or chew them. Administer with food.

How Glycigon M 40mg/500mg Tablet works:

Glycigon M tablets (40mg/500mg) contain a dual-action formulation of gliclazide and metformin, both medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glycigon M 40mg/500mg Tablet ingestion is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycigon M 40mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Exceptionally, a physician might prescribe it in critical circumstances where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glycigon M 40mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glycigon M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glycigon M 40mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glycigon M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A reduced starting dose is typically advised for those with mild to moderate liver disease; the medication is contraindicated in severe cases.

What if you forget to take Glycigon M 40mg/500mg Tablet :

Should you forget a Glycigon M 40mg/500mg Tablet dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glycigon M 40mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glycigon M 40mg/500mg Tablet

Glycigon M 40mg/500mg tablets contain gliclazide and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide enhances insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This dual medication is unsuitable for treating type 1 diabetes.
Glycigon M 40mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Glycigon M 40mg/500mg Tablets may induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry readily available glucose sources such as glucose tablets, honey, or fruit juice.
Glycigon M 40mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent complication of metformin use. To minimize risk, its use is contraindicated in individuals with pre-existing kidney disease, the elderly, and heavy alcohol consumers. Lactic acidosis symptoms may present as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Glycigon M 40mg/500mg Tablet use and seek immediate medical attention.
Glycigon M 40mg/500mg Tablet's prolonged use can indeed lead to vitamin B12 deficiency. This is because the medication impairs the stomach's ability to absorb vitamin B12. Left unaddressed, this deficiency may manifest as anemia, neurological issues, including tingling and numbness in the extremities, muscle weakness, bladder dysfunction, cognitive changes, and impaired coordination. To mitigate these risks, some studies recommend annual supplemental vitamin B12 intake.
Glycigon M 40mg/500mg Tablets are contraindicated in individuals with hypersensitivity to any ingredient or inactive component. Their use is also prohibited in patients exhibiting moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glycigon M 40mg/500mg tablets and alcohol is unsafe. This combination can dangerously reduce blood sugar, potentially leading to lactic acidosis.
Glycigon M 40mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when coupled with a balanced diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glycigon M 40mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Glycigon M 40mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Glycigon M 40mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. The risk is heightened in individuals with pre-existing kidney impairment, the elderly, and those who consume significant quantities of alcohol. Symptoms may present as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms develop, discontinue Glycigon M 40mg/500mg Tablets and seek immediate medical attention.
Glycigon M 40mg/500mg Tablet ingestion may induce vitamin B12 deficiency with prolonged use. This deficiency arises from the medication's interference with gastric vitamin B12 absorption. Left unaddressed, this can lead to anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic annual supplemental vitamin B12 intake is recommended by some experts to mitigate these risks.
Glycigon M 40mg/500mg Tablets are contraindicated in individuals with hypersensitivity to any ingredient or inactive component. The medication should also not be used by patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glycigon M 40mg/500mg tablets with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and heightened lactic acidosis probability.
Glycigon M 40mg/500mg Tab...
44
MRP 54
17% off